United States · FDA National Drug Code directory
naloxone hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70756-850_2a618429-eb01-4c0b-8291-dca1ebc037c4
- Product NDC
- 70756-850
- Form
- INJECTION, SOLUTION
- Composition / generic term
- naloxone hydrochloride
- Labeler
- Lifestar Pharma LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20260219
- Source listing expiry
- 20271231
Source-listed ingredients
- NALOXONE HYDROCHLORIDE — .4 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 VIAL, SINGLE-DOSE in 1 CARTON (70756-850-10) / 1 mL in 1 VIAL, SINGLE-DOSE · 70756-850-10
- 25 VIAL, SINGLE-DOSE in 1 CARTON (70756-850-25) / 1 mL in 1 VIAL, SINGLE-DOSE · 70756-850-25
- 1 VIAL, SINGLE-DOSE in 1 CARTON (70756-850-82) / 1 mL in 1 VIAL, SINGLE-DOSE · 70756-850-82
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →